These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27394174)

  • 1. Mitochondrial impairments contribute to Spinocerebellar ataxia type 1 progression and can be ameliorated by the mitochondria-targeted antioxidant MitoQ.
    Stucki DM; Ruegsegger C; Steiner S; Radecke J; Murphy MP; Zuber B; Saxena S
    Free Radic Biol Med; 2016 Aug; 97():427-440. PubMed ID: 27394174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.
    Mercer JR; Yu E; Figg N; Cheng KK; Prime TA; Griffin JL; Masoodi M; Vidal-Puig A; Murphy MP; Bennett MR
    Free Radic Biol Med; 2012 Mar; 52(5):841-9. PubMed ID: 22210379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of mitochondrial-targeted antioxidant MitoQ against iron ion
    Gan L; Wang Z; Si J; Zhou R; Sun C; Liu Y; Ye Y; Zhang Y; Liu Z; Zhang H
    Toxicol Appl Pharmacol; 2018 Feb; 341():1-7. PubMed ID: 29317239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease.
    McManus MJ; Murphy MP; Franklin JL
    J Neurosci; 2011 Nov; 31(44):15703-15. PubMed ID: 22049413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice.
    Gioscia-Ryan RA; LaRocca TJ; Sindler AL; Zigler MC; Murphy MP; Seals DR
    J Physiol; 2014 Jun; 592(12):2549-61. PubMed ID: 24665093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice.
    Young ML; Franklin JL
    Mol Cell Neurosci; 2019 Dec; 101():103409. PubMed ID: 31521745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1.
    Ripolone M; Lucchini V; Ronchi D; Fagiolari G; Bordoni A; Fortunato F; Mondello S; Bonato S; Meregalli M; Torrente Y; Corti S; Comi GP; Moggio M; Sciacco M
    J Neurosci Res; 2018 Sep; 96(9):1576-1585. PubMed ID: 30113722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Mao P; Manczak M; Shirendeb UP; Reddy PH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease.
    Ng LF; Gruber J; Cheah IK; Goo CK; Cheong WF; Shui G; Sit KP; Wenk MR; Halliwell B
    Free Radic Biol Med; 2014 Jun; 71():390-401. PubMed ID: 24637264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1α.
    Xi Y; Feng D; Tao K; Wang R; Shi Y; Qin H; Murphy MP; Yang Q; Zhao G
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2859-2870. PubMed ID: 29842922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against renal ischemia-reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ.
    Dare AJ; Bolton EA; Pettigrew GJ; Bradley JA; Saeb-Parsy K; Murphy MP
    Redox Biol; 2015 Aug; 5():163-168. PubMed ID: 25965144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is antioxidant potential of the mitochondrial targeted ubiquinone derivative MitoQ conserved in cells lacking mtDNA?
    Lu C; Zhang D; Whiteman M; Armstrong JS
    Antioxid Redox Signal; 2008 Mar; 10(3):651-60. PubMed ID: 17999633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Treatment with Edaravone in a Mouse Model of Spinocerebellar Ataxia 1.
    Sucha M; Benediktova S; Tichanek F; Jedlicka J; Kapl S; Jelinkova D; Purkartova Z; Tuma J; Kuncova J; Cendelin J
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice.
    Rodriguez-Cuenca S; Cochemé HM; Logan A; Abakumova I; Prime TA; Rose C; Vidal-Puig A; Smith AC; Rubinsztein DC; Fearnley IM; Jones BA; Pope S; Heales SJ; Lam BY; Neogi SG; McFarlane I; James AM; Smith RA; Murphy MP
    Free Radic Biol Med; 2010 Jan; 48(1):161-72. PubMed ID: 19854266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoquinone alleviates vincristine-induced neuropathic pain through inhibiting oxidative stress and apoptosis via the improvement of mitochondrial dysfunction.
    Chen XJ; Wang L; Song XY
    Biomed Pharmacother; 2020 May; 125():110003. PubMed ID: 32187955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MitoQ--a mitochondria-targeted antioxidant.
    Tauskela JS
    IDrugs; 2007 Jun; 10(6):399-412. PubMed ID: 17642004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ataxin-1 regulates the cerebellar bioenergetics proteome through the GSK3β-mTOR pathway which is altered in Spinocerebellar ataxia type 1 (SCA1).
    Sánchez I; Balagué E; Matilla-Dueñas A
    Hum Mol Genet; 2016 Sep; 25(18):4021-4040. PubMed ID: 27466200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.
    Dashdorj A; Jyothi KR; Lim S; Jo A; Nguyen MN; Ha J; Yoon KS; Kim HJ; Park JH; Murphy MP; Kim SS
    BMC Med; 2013 Aug; 11():178. PubMed ID: 23915129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.
    Watase K; Gatchel JR; Sun Y; Emamian E; Atkinson R; Richman R; Mizusawa H; Orr HT; Shaw C; Zoghbi HY
    PLoS Med; 2007 May; 4(5):e182. PubMed ID: 17535104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain.
    Wani WY; Gudup S; Sunkaria A; Bal A; Singh PP; Kandimalla RJ; Sharma DR; Gill KD
    Neuropharmacology; 2011 Dec; 61(8):1193-201. PubMed ID: 21784090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.